Accenture plc filings document the regulatory record of a global professional services company, including operating results, material events, governance matters and capital-structure disclosures. The company’s 8-K reports cover quarterly and annual financial results, non-GAAP measures such as free cash flow and local-currency revenue and bookings, and material financing arrangements including senior unsecured revolving credit facilities used for general corporate purposes and to support its commercial paper program.
Proxy materials describe shareholder voting matters, board and executive compensation disclosures, equity award information and governance practices. Other filings record leadership and organizational changes, including Accenture’s integrated Reinvention Services business unit, as well as risk, liquidity and financial reporting topics relevant to its consulting, technology and operations services model.
Martin Brudermueller, an Accenture plc (ACN) director, received 5 restricted share units (RSUs) under anti-dilution provisions tied to prior RSU awards to reflect Accenture's cash dividend. The reported transaction shows an execution price reference of $247.57 per share and indicates 1,128 Class A ordinary shares beneficially owned by the reporting person following the grant. The Form 4 was submitted to disclose this non-derivative acquisition and clarifies the RSUs were granted specifically to adjust awards for the company dividend.
Alan C. Jope, a director of Accenture plc (ACN), reported an acquisition of 1,978 Class A ordinary shares on 08/15/2025. The shares were received as a grant of Restricted Share Units (RSUs) under anti-dilution provisions tied to a cash dividend; the report shows a deemed price of $247.57 per share. Following the transaction, Mr. Jope beneficially owns 1,978 shares directly. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses a routine equity award adjustment rather than an open-market trade.
Accenture plc (ACN) Form 4: Director Nancy McKinstry was reported as acquiring restricted share units tied to Accenture Class A ordinary shares on 08/15/2025. The filing shows an acquisition (Code A) related to anti-dilution adjustments for previously granted RSU awards to reflect a cash dividend payment. The reported post-transaction beneficial ownership is 7,260 shares held directly. The transaction is documented with a reported per-share amount of $247.57 and was signed by an attorney-in-fact on behalf of the reporting person on 08/18/2025.
Jennifer Nason, a director of Accenture plc (ACN), reported an acquisition of 619 Class A ordinary shares through the grant of restricted share units (RSUs). The transaction date was 08/15/2025 and the form was filed with a signature dated 08/18/2025.
The RSUs were granted pursuant to the anti-dilution provisions of previously awarded RSU awards to reflect Accenture's payment of a cash dividend. The reported price associated with the RSU grant is $247.57 and ownership is reported as direct.
Paula A. Price, a director of Accenture plc (ACN), was granted 7,361 Class A ordinary shares as Restricted Share Units (RSUs) on 08/15/2025 at an indicated price of $247.57 per share. The Form 4 reports the acquisition code "A" and explains these RSUs were issued pursuant to anti-dilution provisions of previously granted awards to reflect Accenture's cash dividend. After the grant, Ms. Price beneficially owns 7,361 shares in direct form. The filing was signed by an attorney-in-fact on 08/18/2025.
Accenture plc (ACN): Director Venkata S. M. Renduchintala reported a Section 16 transaction dated 08/15/2025 showing acquisition of 3,703 Class A ordinary shares. The Form 4 indicates the shares were granted as Restricted Share Units (RSUs) under anti-dilution provisions tied to a cash dividend and lists a price of $247.57. The filing shows the shares are held directly and was signed on behalf of the reporting person by an attorney-in-fact on 08/18/2025.
Arun Sarin, a director of Accenture plc (ticker ACN), reported an acquisition on 08/15/2025 of 8,473 Class A ordinary shares via grant (Transaction Code A) of restricted share units. The grant was made pursuant to anti-dilution provisions tied to previously awarded RSUs to reflect Accenture's payment of a cash dividend. The reported price per share is $247.57, and the amount beneficially owned following the transaction is listed as 8,473 shares. The Form 4 was signed on behalf of Mr. Sarin by an attorney-in-fact on 08/18/2025.
Accenture plc (ACN) director Tracey Thomas received a grant of restricted share units (RSUs) tied to prior awards to reflect a cash dividend. The Form 4 shows a transaction dated 08/15/2025 recorded as an acquisition (code A) with a reference price of $247.57. Following the reported transaction the filing lists 8,573 Class A ordinary shares beneficially owned. The filing was signed on behalf of Tracey Thomas by an attorney-in-fact on 08/18/2025. The explanatory note states the grant resulted from anti-dilution provisions of previously granted RSU awards to reflect Accenture's dividend payment.
Masahiko Uotani, a director of Accenture plc (ACN), received a grant of 619 Class A ordinary shares recorded as restricted share units (RSUs) on 08/15/2025. The Form 4 reports the shares were issued pursuant to anti-dilution provisions tied to previously granted RSU awards to reflect Accenture's cash dividend. The reported transaction lists a price of $247.57 and shows 619 shares beneficially owned following the grant in a direct ownership form. The filing was signed by an attorney-in-fact on 08/18/2025. No other transactions, derivative holdings, or additional compensation details are disclosed in this Form 4.
Accenture plc (ACN) Form 4: Atsushi Egawa, listed as Co-CEO Asia Pacific and an officer of Accenture, reported a transaction dated 08/15/2025. The filing shows a grant of restricted share units (RSUs) issued pursuant to anti-dilution provisions tied to previously granted RSU awards to reflect Accenture's cash dividend. The reported transaction lists Class A ordinary shares related to the RSU grant and indicates an acquisition event. The form was signed by an attorney-in-fact on 08/18/2025. The filing discloses direct and indirect holdings, including shares held by an immediate family member.